Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

US National Institutes of Health (NIH) grant open #PAR-24-325

Response due Sep 07, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting cooperative agreement applications under the U01 mechanism for bioengineering research conducted in partnership with industry. Clinical trials are optional under this program announcement. The opportunity is designed to foster collaborative research between academic/research institutions and industry partners in the bioengineering domain. The solicitation is open for a multi-year window from November 2024 through September 2027.

What they want

Technical requirements

Must involve a partnership with an industry entity
Clinical trial component is optional
Must align with bioengineering research scope
U01 cooperative agreement mechanism applies

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

Extremely long open window (nearly 3 years) with rolling submissions — may favor well-connected applicants with established industry relationships
Minimal scope detail provided in the synopsis; full requirements require review of complete PAR-24-325 program announcement

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Bioengineering Partnerships with Industry …

Due Sep 07

Onboard ↗